volume 93, issue 3, P317-322 1998
DOI: 10.1111/j.1572-0241.1998.00317.x
View full text
|
|
Share
F Parente, Bianchi G Porro

Abstract: Foscarnet and ganciclovir appear to be similarly effective and safe in the induction therapy of AIDS-related CMV esophagitis. Consequently, the choice of the anti-CMV agent should be tailored to the individual patient according to the different toxicity profiles of the two drugs.